Literature DB >> 12408980

Identification of an alternatively spliced isoform of the fyn tyrosine kinase.

Jeffrey F Goldsmith1, Craig G Hall, T Prescott Atkinson.   

Abstract

Two isoforms of the src-family tyrosine kinase p59fyn have been shown to arise through alternative splicing of exon 7 of the fyn gene. These isoforms have been designated fynT, expressed in hematopoietic cells, and fynB, expressed in the brain. Here, we describe a novel isoform, fynDelta7, in which exon 7 is absent. FynDelta7 mRNA transcripts have been identified in peripheral blood mononuclear cells from all individuals tested thus far and semi-quantitative RT-PCR indicates that this fyn transcript is expressed at near wild-type levels. Transcripts coding for the fynDelta7 isoform can be detected in purified B cells, T cells, NK cells, and monocytes, indicating that it is not lineage specific. We further show that the message isolated is functional using an in vitro expression system and by its expression in COS cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408980     DOI: 10.1016/s0006-291x(02)02510-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Targeting Fyn Kinase in Alzheimer's Disease.

Authors:  Haakon B Nygaard
Journal:  Biol Psychiatry       Date:  2017-06-13       Impact factor: 13.382

Review 2.  Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance.

Authors:  Eijiro Yamada; Ting-Wen A Lee; Jeffrey E Pessin; Claire C Bastie
Journal:  Future Med Chem       Date:  2010-12       Impact factor: 3.808

3.  Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease.

Authors:  Jeffrey A Zahratka; Yvonne Shao; McKenzie Shaw; Kaitlin Todd; Shane V Formica; Maria Khrestian; Thomas Montine; James B Leverenz; Lynn M Bekris
Journal:  Neurobiol Aging       Date:  2016-11-15       Impact factor: 4.673

Review 4.  Fyn: a novel molecular target in cancer.

Authors:  Yoshihito D Saito; Ana R Jensen; Ravi Salgia; Edwin M Posadas
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

Review 5.  Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target?

Authors:  Bianca Guglietti; Srisankavi Sivasankar; Sanam Mustafa; Frances Corrigan; Lyndsey E Collins-Praino
Journal:  Mol Neurobiol       Date:  2021-08-25       Impact factor: 5.590

6.  Subcellular localization of Mayven following expression of wild type and mutant EGFP tagged cDNAs.

Authors:  Paul Montague; Peter G E Kennedy; Susan C Barnett
Journal:  BMC Neurosci       Date:  2010-05-26       Impact factor: 3.288

Review 7.  Alternative splicing in the NF-kappaB signaling pathway.

Authors:  Joshua R Leeman; Thomas D Gilmore
Journal:  Gene       Date:  2008-07-22       Impact factor: 3.688

Review 8.  Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?

Authors:  Manu Vatish; Eijiro Yamada; Jeffrey E Pessin; Claire C Bastie
Journal:  Arch Physiol Biochem       Date:  2009-10       Impact factor: 4.076

9.  Identification of alternatively spliced Dab1 and Fyn isoforms in pig.

Authors:  Huan Long; Hans H Bock; Ting Lei; Xuejun Chai; Jihong Yuan; Joachim Herz; Michael Frotscher; Zaiqing Yang
Journal:  BMC Neurosci       Date:  2011-02-05       Impact factor: 3.288

Review 10.  Fyn kinase inhibition as a novel therapy for Alzheimer's disease.

Authors:  Haakon B Nygaard; Christopher H van Dyck; Stephen M Strittmatter
Journal:  Alzheimers Res Ther       Date:  2014-02-05       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.